PDCO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PDCO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.
Patterson's Capital Expenditure for the three months ended in Jan. 2025 was $-20.23 Mil. Its Cash Flow from Operations for the three months ended in Jan. 2025 was $-276.39 Mil.
GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.
The historical data trend for Patterson's Capex-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Patterson Annual Data | |||||||||||||||||||||
Trend | Apr15 | Apr16 | Apr17 | Apr18 | Apr19 | Apr20 | Apr21 | Apr22 | Apr23 | Apr24 | |||||||||||
Capex-to-Operating-Cash-Flow | Get a 7-Day Free Trial |
![]() |
![]() |
- | - | - | - | - |
Patterson Quarterly Data | ||||||||||||||||||||
Apr20 | Jul20 | Oct20 | Jan21 | Apr21 | Jul21 | Oct21 | Jan22 | Apr22 | Jul22 | Oct22 | Jan23 | Apr23 | Jul23 | Oct23 | Jan24 | Apr24 | Jul24 | Oct24 | Jan25 | |
Capex-to-Operating-Cash-Flow | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | - | - | - | - |
For the Medical Distribution subindustry, Patterson's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Distribution industry and Healthcare sector, Patterson's Capex-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Patterson's Capex-to-Operating-Cash-Flow falls into.
Patterson's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Apr. 2024 is calculated as
Capex-to-Operating-Cash-Flow | = | - Capital Expenditure | / | Cash Flow from Operations |
= | - (-67.626) | / | -789.378 | |
= | N/A |
Patterson's Capex-to-Operating-Cash-Flow for the quarter that ended in Jan. 2025 is calculated as
Capex-to-Operating-Cash-Flow | = | - Capital Expenditure | / | Cash Flow from Operations |
= | - (-20.232) | / | -276.393 | |
= | N/A |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Patterson (NAS:PDCO) Capex-to-Operating-Cash-Flow Explanation
Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.
Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.
Thank you for viewing the detailed overview of Patterson's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Donald Zurbay | officer: Chief Financial Officer | C/O ST. JUDE MEDICAL, INC., ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117 |
Samantha L Bergeson | officer: CHRO | 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120 |
Kevin Michael Barry | officer: Chief Financial Officer | 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120 |
Les B Korsh | officer: VP, General Counsel | 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55110 |
Timothy E Rogan | officer: President - Dental | 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120 |
Meenu Agarwal | director | 7246 E MERCER WAY, MERCER ISLAND WA 98040 |
Andrea L. Frohning | officer: Chief Human Resources Officer | C/O DENTSLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Philip Mckoy | director | 120 BROADWAY, SUITE 200, SANTA MONICA CA 90401 |
Jody H Feragen | director | 1 HORMEL PLACE, AUSTIN TX 55912 |
Eric R Shirley | officer: President-Patterson Dental | 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120 |
Francis Joseph Malecha | director | 9900 WEST 109TH STREET, SUITE 100, OVERLAND PARK KS 66210 |
Robert Frenzel | director | 414 NICOLLET MALL, MINNEAPOLIS MN 55401 |
Dennis W Goedken | officer: Interim CFO | 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120 |
Ann B Gugino | officer: Vice President | 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120 |
John D Buck | director | 4201 GULF SHORE BLVD NORTH, APT 1703N, NAPLES FL 34103 |
From GuruFocus
By PRNewswire • 12-11-2024
By GuruFocus News • 12-05-2024
By Business Wire • 12-11-2024
By GuruFocus News • 12-06-2024
By Business Wire • 12-11-2024
By GuruFocus News • 02-28-2025
By GuruFocus News • 04-14-2025
By Muslim Farooque • 12-11-2024
By Faizan Farooque • 12-11-2024
By Business Wire • 02-26-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.